The Orosomucoid 1 protein is involved in the vitamin D - mediated macrophage de-activation process

Experimental Cell Research

Volumn 319, Issue 20, 2013, Pages 3201-3213

  Gemelli, Claudia ^a   Martello, Andrea ^a   Montanari, Monica ^a   Zanocco Marani, Tommaso ^a   Salsi, Valentina ^a   Zappavigna, Vincenzo ^a   Parenti, Sandra ^a   Vignudelli, Tatiana ^a   Selmi, Tommaso ^a   Ferrari, Sergio ^a   Grande, Alexis ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Alpha 1 acid glycoprotein; Gene regulation; Monocyte; Orosomucoid 1; Vitamin D

Indexed keywords

COLECALCIFEROL; LUCIFERASE; OROSOMUCOID; OROSOMUCOID 1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MACROPHAGE MIGRATION INHIBITION; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSACTIVATION; VITAMIN D RESPONSIVE ELEMENT;

EID: 84887206646     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.08.017     Document Type: Article

References (50)

1. Carlberg C., Polly P. Gene regulation by vitamin D3. Crit. Rev. Eukaryotic Gene Exp. 1998, 8:19-42.
2. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80:1689S-1696SS.
3. Issa L.L., Leong G.M., Eisman J.A. Molecular mechanism of vitamin D receptor action. Inflamm. Res. 1998, 47:451-475.
4. Di Rosa M., Malaguarnera M., Nicoletti F., Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology 2011, 134:123-139.
5. Wang T.T., Tavera-Mendoza L.E., Laperriere D., Libby E., MacLeod N.B., Nagai Y., et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 2005, 19:2685-2695.
6. Schrader M., Nayeri S., Kahlen J.P., Muller K.M., Carlberg C. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell Biol. 1995, 15:1154-1161.
7. Tavera-Mendoza L., Wang T.T., Lallemant B., Zhang R., Nagai Y., Bourdeau V., et al. Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep. 2006, 7:180-185.
8. Studzinski G.P., McLane J.A., Uskokovic M.R. Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit. Rev. Eukaryot. Gene. Expr. 1993, 3:279-312.
9. Hmama Z., Nandan D., Sly L., Knutson K.L., Herrera-Velit P., Reiner N.E. 1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J. Exp. Med. 1999, 190:1583-1594.
10. Hughes P.J., Marcinkowska E., Gocek E., Studzinski G.P., Brown G. Vitamin D3-driven signals for myeloid cell differentiation - implications for differentiation therapy. Leuk Res. 2009, 34:553-565.
11. Grande A., Montanari M., Tagliafico E., Manfredini R., Zanocco Marani T., Siena M., et al. Physiological levels of 1alpha, 25 dihydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors. J. Leukocyte Biol. 2002, 71:641-651.
12. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 2008, 8:685-698.
13. Tagliafico E., Tenedini E., Bergamaschi A., Manfredini R., Percudani R., Siena M., et al. Gene expression profile of Vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes. Cell Death Differ. 2002, 9:1185-1195.
14. Grande A., Manfredini R., Pizzanelli M., Tagliafico E., Balestri R., Trevisan F., et al. Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation. Cell Death Differ. 1997, 4:497-505.
15. Gemelli C., Orlandi C., Zanocco Marani T., Martello A., Vignudelli T., Ferrari F., et al. The vitamin D3/Hox-A10 pathway supports MafB function during the monocyte differentiation of human CD34+ hemopoietic progenitors. J. Immunol. 2008, 181:5660-5672.
16. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19:1067-1077.
17. Du H., Daftary G.S., Lalwani S.I., Taylor H.S. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol. Endocrinol. 2005, 19:2222-2233.
18. Zhang D.E., Hetherington C.J., Gonzalez D.A., Chen H.M., Tenen D.G. Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3. J. Immunol. 1994, 153:3276-3284.
19. Matilainen J.M., Husso T., Toropainen S., Seuter S., Turunen M.P., Gynther P., et al. Primary effect of 1alpha,25(OH)(2)D(3) on IL-10 expression in monocytes is short-term down-regulation. Biochim. Biophys. Acta 2010, 1803:1276-1286.
20. Gemelli C., Montanari M., Tenedini E., Zanocco Marani T., Vignudelli T., Siena M., et al. Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells. Cell Death Differ. 2006, 13:1686-1696.
21. Baeke F., Korf H., Overbergh L., van Etten E., Verstuyf A., Gysemans C., et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J. Steroid Biochem. Mol. Biol. 2010, 121:221-227.
22. Matilainen J.M., Rasanen A., Gynther P., Vaisanen S. The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1alpha,25(OH)2D3 target genes. J. Steroid Biochem. Mol. Biol. 2010, 121:142-145.
23. Gynther P., Toropainen S., Matilainen J.M., Seuter S., Carlberg C., Vaisanen S. Mechanism of 1alpha,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B. Biochim. Biophys. Acta 2011, 1813:810-818.
24. Cohen-Lahav M., Shany S., Tobvin D., Chaimovitz C., Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol. Dial Transplant. 2006, 21:889-897.
25. Alroy I., Towers T.L., Freedman L.P. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 1995, 15:5789-5799.
26. Fournier T., Medjoubi N.N., Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta 2000, 1482:157-171.
27. Lee Y.S., Choi J.W., Hwang I., Lee J.W., Lee J.H., Kim A.Y., et al. Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J. Biol. Chem. 2010, 285:22174-22185.
28. Hochepied T., Berger F.G., Baumann H., Libert C. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev. 2003, 14:25-34.
29. Fournier T., Bouach N., Delafosse C., Crestani B., Aubier M. Inducible expression and regulation of the alpha 1-acid glycoprotein gene by alveolar macrophages: prostaglandin E2 and cyclic AMP act as new positive stimuli. J. Immunol. 1999, 163:2883-2890.
30. Montanari M., Gemelli C., Tenedini E., Zanocco Marani T., Vignudelli T., Siena M., et al. Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors. Cell Death Differ. 2005, 12:1588-1600.
31. Su S.J., Yang B.C., Wang Y.S., Yeh T.M. Alpha 1-acid glycoprotein-induced tumor necrosis factor-alpha secretion of human monocytes is enhanced by serum binding proteins and depends on protein tyrosine kinase activation. Immunopharmacology 1999, 41:21-29.
32. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
33. Parenti S., Ferrarini F., Zini R., Montanari M., Losi L., Canovi B., et al. Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells. Aliment Pharmacol Ther. 2009, 31:108-119.
34. Nordeen S.K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 1988, 6:454-458.
35. Noda M., Vogel R.L., Craig A.M., Prahl J., DeLuca H.F., Denhardt D.T. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. USA 1990, 87:9995-9999.
36. Shen Q., Christakos S. The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J. Biol. Chem. 2005, 280:40589-40598.
37. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., et al. The human genome browser at UCSC. Genome Res. 2002, 12:996-1006.
38. Matilainen M., Malinen M., Saavalainen K., Carlberg C. Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res. 2005, 33:5521-5532.
39. Satoh J., Tabunoki H. Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes. Multiple Sclerosis J. 2013, 19:1035-1045.
40. Heikkinen S., Vaisanen S., Pehkonen P., Seuter S., Benes V., Carlberg C. Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 2011, 39:9181-9193.
41. Pike J.W., Meyer M.B., Martowicz M.L., Bishop K.A., Lee S.M., Nerenz R.D., et al. Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 2010, 121:130-135.
42. Meyer M.B., Goetsch P.D., Pike J.W. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J. Steroid Biochem. Mol. Biol. 2010, 121:136-141.
43. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
44. Eloranta J.J., Hiller C., Juttner M., Kullak-Ublick G.A. The SLCO1A2 gene, Encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor. Mol. Pharmacol. 2012, 82:37-46.
45. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: modulator of the immune system. Curr. Opinion Pharmacol. 2010, 10:482-496.
46. Baeke F., Gysemans C., Korf H., Mathieu C. Vitamin D insufficiency: implications for the immune system. Pediatr. Nephrol. 2010, 25:1597-1606.
47. Kang S.W., Kim S.H., Lee N., Lee W.W., Hwang K.A., Shin M.S., et al. 1,25-Dihyroxyvitamin D3 Promotes FOXP3 Expression via Binding to Vitamin D Response Elements in Its Conserved Noncoding Sequence Region. J. Immunol. 2012, 188:5276-5282.
48. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010, 20:1352-1360.
49. Atemezem A., Mbemba E., Vassy R., Slimani H., Saffar L., Gattegno L. Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages. Biochem. J. 2001, 356:121-128.
50. Komori H., Watanabe H., Shuto T., Kodama A., Maeda H., Watanabe K., et al. alpha(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress. J. Biol. Chem. 2012, 287:30688-30700.